Contact Us

Service Line:+1-315-239-3085

Address:FL-4, Building A5, International Enterprise Community, Tianjin, China

Email:info@kmdbioscience.com

Online Inquery

  •   
  •   
  •   
  • Refresh

Anti-Staphylococcus Epidermidis Lipoteichoic Acid Recombinant Antibody

Product Information
Catalog Number YR1165
Product Name Anti-Staphylococcus Epidermidis Lipoteichoic Acid Recombinant Antibody
Molecular Name Pagibaximab
Alias Anti-Lipoteichoic Acid Recombinant Antibody, Research Grade Pagibaximab
CAS Number 595566-61-3
Target Lipoteichoic Acid[Staphylococcus epidermidis]
Isotype IgG1 Kappa
Clonity Monoclonal
Source CHO Cells
Size 1mg, 5mg
Concentration 1mg/ml
Purity >95% as determined by SDS-PAGE
Applications FuncS, IF, Neut, ELISA, FCM, IP
Buffer PBS, pH7.5
Background Pagibaximab is a chimeric monoclonal antibody for the prevention of staphylococcal sepsis in infants with low birth weight. As of March 2010, it is undergoing Phase II/III clinical trials.
Storage It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note This product is for research use only.